ID   K7N5M4_HUMAN            Unreviewed;       259 AA.
AC   K7N5M4;
DT   09-JAN-2013, integrated into UniProtKB/TrEMBL.
DT   09-JAN-2013, sequence version 1.
DT   28-JAN-2026, entry version 80.
DE   SubName: Full=Human nkt tcr beta chain {ECO:0000313|PDB:4EN3};
GN   Name=B2M {ECO:0000313|PDB:4EN3};
GN   ORFNames=HDCMA22P {ECO:0000313|PDB:4EN3};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|PDB:4EN3};
RN   [1] {ECO:0007829|PDB:3PQY}
RP   X-RAY CRYSTALLOGRAPHY (3.19 ANGSTROMS) OF 107-249, AND DISULFIDE BONDS.
RX   PubMed=21606376; DOI=10.1073/pnas.1106851108;
RA   Day E.B., Guillonneau C., Gras S., La Gruta N.L., Vignali D.A.,
RA   Doherty P.C., Purcell A.W., Rossjohn J., Turner S.J.;
RT   "Structural basis for enabling T-cell receptor diversity within biased
RT   virus-specific CD8+ T-cell responses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:9536-9541(2011).
RN   [2] {ECO:0000313|PDB:4EN3, ECO:0007829|PDB:4EN3}
RP   X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) IN COMPLEX WITH
RP   N-ACETYL-D-GLUCOSAMINE, AND ACTIVE SITE.
RX   PubMed=23109910; DOI=10.1371/journal.pbio.1001412;
RA   Lopez-Sagaseta J., Kung J.E., Savage P.B., Gumperz J., Adams E.J.;
RT   "The molecular basis for recognition of CD1d/alpha-galactosylceramide by a
RT   human non-Valpha24 T cell receptor.";
RL   PLoS Biol. 10:e1001412-e1001412(2012).
RN   [3] {ECO:0007829|PDB:4MNH, ECO:0007829|PDB:4NDM}
RP   X-RAY CRYSTALLOGRAPHY (3.01 ANGSTROMS) OF 120-248, AND DISULFIDE BONDS.
RX   PubMed=24239091; DOI=10.1016/j.immuni.2013.11.001;
RA   Luoma A.M., Castro C.D., Mayassi T., Bembinster L.A., Bai L., Picard D.,
RA   Anderson B., Scharf L., Kung J.E., Sibener L.V., Savage P.B., Jabri B.,
RA   Bendelac A., Adams E.J.;
RT   "Crystal structure of Vdelta1 T cell receptor in complex with CD1d-
RT   sulfatide shows MHC-like recognition of a self-lipid by human gammadelta T
RT   cells.";
RL   Immunity 39:1032-1042(2013).
RN   [4] {ECO:0007829|PDB:5WLG}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 117-118 AND 120-249, AND
RP   DISULFIDE BONDS.
RX   PubMed=29150238; DOI=10.1016/j.immuni.2017.10.013;
RA   Van Braeckel-Budimir N., Gras S., Ladell K., Josephs T.M., Pewe L.,
RA   Urban S.L., Miners K.L., Farenc C., Price D.A., Rossjohn J., Harty J.T.;
RT   "A T Cell Receptor Locus Harbors a Malaria-Specific Immune Response Gene.";
RL   Immunity 47:835-847.e4(2017).
RN   [5] {ECO:0007829|PDB:5MEN}
RP   X-RAY CRYSTALLOGRAPHY (2.81 ANGSTROMS) OF 125-249, AND DISULFIDE BONDS.
RX   PubMed=27903649; DOI=10.1074/jbc.m116.741603;
RA   Cole D.K., van den Berg H.A., Lloyd A., Crowther M.D., Beck K.,
RA   Ekeruche-Makinde J., Miles J.J., Bulek A.M., Dolton G., Schauenburg A.J.,
RA   Wall A., Fuller A., Clement M., Laugel B., Rizkallah P.J., Wooldridge L.,
RA   Sewell A.K.;
RT   "Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone
RT   That Recognizes a Peptide Derived from Human Telomerase Reverse
RT   Transcriptase.";
RL   J. Biol. Chem. 292:802-813(2017).
RN   [6] {ECO:0007829|PDB:6BJ2, ECO:0007829|PDB:6BJ3}
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 7-249 IN COMPLEX WITH ZN(2+), AND
RP   DISULFIDE BONDS.
RX   PubMed=30053426; DOI=10.1016/j.cell.2018.06.017;
RA   Sibener L.V., Fernandes R.A., Kolawole E.M., Carbone C.B., Liu F.,
RA   McAffee D., Birnbaum M.E., Yang X., Su L.F., Yu W., Dong S., Gee M.H.,
RA   Jude K.M., Davis M.M., Groves J.T., Goddard W.A., Heath J.R., Evavold B.D.,
RA   Vale R.D., Garcia K.C.;
RT   "Isolation of a Structural Mechanism for Uncoupling T Cell Receptor
RT   Signaling from Peptide-MHC Binding.";
RL   Cell 174:672-687.e27(2018).
RN   [7] {ECO:0007829|PDB:6AT6}
RP   X-RAY CRYSTALLOGRAPHY (1.42 ANGSTROMS) OF 120-249, AND DISULFIDE BONDS.
RX   PubMed=29531227; DOI=10.1038/s41467-018-03321-w;
RA   Chan K.F., Gully B.S., Gras S., Beringer D.X., Kjer-Nielsen L., Cebon J.,
RA   McCluskey J., Chen W., Rossjohn J.;
RT   "Divergent T-cell receptor recognition modes of a HLA-I restricted extended
RT   tumour-associated peptide.";
RL   Nat. Commun. 9:1026-1026(2018).
RN   [8] {ECO:0007829|PDB:6CW6}
RP   X-RAY CRYSTALLOGRAPHY (2.85 ANGSTROMS) OF 4-248, AND DISULFIDE BONDS.
RX   PubMed=31391251; DOI=10.1074/jbc.ra119.009963;
RA   Wang J., Guillaume J., Janssens J., Remesh S.G., Ying G., Bitra A.,
RA   Van Calenbergh S., Zajonc D.M.;
RT   "A molecular switch in mouse CD1d modulates natural killer T cell
RT   activation by alpha-galactosylsphingamides.";
RL   J. Biol. Chem. 294:14345-14356(2019).
RN   [9] {ECO:0007829|PDB:6D78, ECO:0007829|PDB:6DKP}
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 5-249, AND DISULFIDE BONDS.
RX   PubMed=30617019; DOI=10.1016/j.ymthe.2018.12.010;
RA   Hellman L.M., Foley K.C., Singh N.K., Alonso J.A., Riley T.P., Devlin J.R.,
RA   Ayres C.M., Keller G.L.J., Zhang Y., Vander Kooi C.W., Nishimura M.I.,
RA   Baker B.M.;
RT   "Improving T Cell Receptor On-Target Specificity via Structure-Guided
RT   Design.";
RL   Mol. Ther. 27:300-313(2019).
RN   [10] {ECO:0007829|PDB:6Q3S}
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 123-249, AND DISULFIDE BONDS.
RX   PubMed=31324691; DOI=10.1126/sciimmunol.aav0860;
RA   Moritz A., Anjanappa R., Wagner C., Bunk S., Hofmann M., Pszolla G.,
RA   Saikia A., Garcia-Alai M., Meijers R., Rammensee H.G., Springer S.,
RA   Maurer D.;
RT   "High-throughput peptide-MHC complex generation and kinetic screenings of
RT   TCRs with peptide-receptive HLA-A*02:01 molecules.";
RL   Sci. Immunol. 4:eaav0860-eaav0860(2019).
RN   [11] {ECO:0007829|PDB:6R2L}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 5-5 AND 107-249, AND DISULFIDE
RP   BONDS.
RX   PubMed=32310221; DOI=10.1172/jci130562;
RA   Holland C.J., Crean R.M., Pentier J.M., de Wet B., Lloyd A.,
RA   Srikannathasan V., Lissin N., Lloyd K.A., Blicher T.H., Conroy P.J.,
RA   Hock M., Pengelly R.J., Spinner T.E., Cameron B., Potter E.A.,
RA   Jeyanthan A., Molloy P.E., Sami M., Aleksic M., Liddy N., Robinson R.A.,
RA   Harper S., Lepore M., Pudney C.R., van der Kamp M.W., Rizkallah P.J.,
RA   Jakobsen B.K., Vuidepot A., Cole D.K.;
RT   "Specificity of bispecific T cell receptors and antibodies targeting
RT   peptide-HLA.";
RL   J. Clin. Invest. 130:2673-2688(2020).
RN   [12] {ECO:0007829|PDB:6V80}
RP   X-RAY CRYSTALLOGRAPHY (3.53 ANGSTROMS) OF 6-96; 101-101 AND 106-249, AND
RP   DISULFIDE BONDS.
RX   DOI=10.1038/s43018-020-00111-6;
RA   Shahine A., Rossjohn J.;
RT   "A single-domain bispecific antibody targeting CD1d and the NKT T-cell
RT   receptor induces a potent antitumor response.";
RL   Nat. Cancer 1:1054-1065(2020).
RN   [13] {ECO:0007829|PDB:6U07}
RP   X-RAY CRYSTALLOGRAPHY (1.76 ANGSTROMS) OF 120-249, AND DISULFIDE BONDS.
RX   PubMed=32393818; DOI=10.1038/s41467-020-16231-7;
RA   Froning K., Maguire J., Sereno A., Huang F., Chang S., Weichert K.,
RA   Frommelt A.J., Dong J., Wu X., Austin H., Conner E.M., Fitchett J.R.,
RA   Heng A.R., Balasubramaniam D., Hilgers M.T., Kuhlman B., Demarest S.J.;
RT   "Computational stabilization of T cell receptors allows pairing with
RT   antibodies to form bispecifics.";
RL   Nat. Commun. 11:2330-2330(2020).
RN   [14] {ECO:0007829|PDB:6PY2}
RP   X-RAY CRYSTALLOGRAPHY (2.83 ANGSTROMS) OF 7-249, AND DISULFIDE BONDS.
RX   PubMed=31974305; DOI=10.1073/pnas.1914308117;
RA   Ting Y.T., Dahal-Koirala S., Kim H.S.K., Qiao S.W., Neumann R.S.,
RA   Lundin K.E.A., Petersen J., Reid H.H., Sollid L.M., Rossjohn J.;
RT   "A molecular basis for the T cell response in HLA-DQ2.2 mediated celiac
RT   disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 117:3063-3073(2020).
RN   [15] {ECO:0007829|PDB:7M72}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 4-249, AND DISULFIDE BONDS.
RX   PubMed=34759313; DOI=10.1038/s41586-021-04083-0;
RA   Oh S.F., Praveena T., Song H., Yoo J.S., Jung D.J., Erturk-Hasdemir D.,
RA   Hwang Y.S., Lee C.C., Le Nours J., Kim H., Lee J., Blumberg R.S.,
RA   Rossjohn J., Park S.B., Kasper D.L.;
RT   "Host immunomodulatory lipids created by symbionts from dietary amino
RT   acids.";
RL   Nature 600:302-307(2021).
RN   [16] {ECO:0007829|PDB:7NDQ, ECO:0007829|PDB:7NDU}
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 106-106 AND 120-249, AND
RP   DISULFIDE BONDS.
RX   PubMed=35108401; DOI=10.1002/eji.202149745;
RA   Barber C., De Souza V.A., Paterson R.L., Martin-Urdiroz M., Mulakkal N.C.,
RA   Srikannathasan V., Connolly M., Phillips G., Foong-Leong T., Pengelly R.,
RA   Karuppiah V., Grant T., Dembek M., Verma A., Gibbs-Howe D., Blicher T.H.,
RA   Knox A., Robinson R.A., Cole D.K., Leonard S.;
RT   "Structure-guided stabilization of pathogen-derived peptide-HLA-E complexes
RT   using non-natural amino acids conserves native TCR recognition.";
RL   Eur. J. Immunol. 52:618-632(2022).
RN   [17] {ECO:0007829|PDB:7N4K, ECO:0007829|PDB:7N5C}
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 107-249, AND DISULFIDE BONDS.
RX   PubMed=35999236; DOI=10.1038/s41467-022-32692-4;
RA   Szeto C., Zareie P., Wirasinha R.C., Zhang J.B., Nguyen A.T.,
RA   Riboldi-Tunnicliffe A., La Gruta N.L., Gras S., Daley S.R.;
RT   "Covalent TCR-peptide-MHC interactions induce T cell activation and
RT   redirect T cell fate in the thymus.";
RL   Nat. Commun. 13:4951-4951(2022).
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000256|ARBA:ARBA00004236}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   PDB; 3PQY; X-ray; 3.19 A; E/J/O/T=107-249.
DR   PDB; 4EN3; X-ray; 2.57 A; B=1-259.
DR   PDB; 4MNH; X-ray; 3.30 A; A/C=2-259.
DR   PDB; 4NDM; X-ray; 3.01 A; A=120-248.
DR   PDB; 5MEN; X-ray; 2.81 A; E=125-249.
DR   PDB; 5WLG; X-ray; 2.10 A; E/J=4-5, E/J=107-107, E/J=109-118, E/J=120-249.
DR   PDB; 6AT6; X-ray; 1.42 A; B=120-249.
DR   PDB; 6BJ2; X-ray; 3.35 A; E=5-249.
DR   PDB; 6BJ3; X-ray; 1.90 A; H=7-249.
DR   PDB; 6BJ8; X-ray; 1.75 A; H=7-249.
DR   PDB; 6CW6; X-ray; 2.85 A; D=4-248.
DR   PDB; 6D78; X-ray; 2.35 A; E=5-249.
DR   PDB; 6DKP; X-ray; 2.97 A; E=120-249.
DR   PDB; 6PY2; X-ray; 2.83 A; E=7-249.
DR   PDB; 6Q3S; X-ray; 2.50 A; E=123-249.
DR   PDB; 6R2L; X-ray; 2.30 A; E=5-5, E=107-249.
DR   PDB; 6U07; X-ray; 1.76 A; B=120-249.
DR   PDB; 6V80; X-ray; 3.53 A; D/I=6-96, D/I=101-101, D/I=106-249.
DR   PDB; 7M72; X-ray; 2.40 A; D=4-249.
DR   PDB; 7N4K; X-ray; 1.85 A; E=107-249.
DR   PDB; 7N5C; X-ray; 1.87 A; E=107-249.
DR   PDB; 7N5P; X-ray; 2.09 A; E=107-249.
DR   PDB; 7NDQ; X-ray; 2.55 A; EEE=106-106, EEE=120-249.
DR   PDB; 7NDU; X-ray; 2.90 A; EEE=120-249.
DR   PDBsum; 4EN3; -.
DR   PDBsum; 4MNH; -.
DR   PDBsum; 4NDM; -.
DR   PDBsum; 5WLG; -.
DR   PDBsum; 6PY2; -.
DR   PDBsum; 6R2L; -.
DR   PDBsum; 6U07; -.
DR   AlphaFoldDB; K7N5M4; -.
DR   SMR; K7N5M4; -.
DR   OrthoDB; 9949628at2759; -.
DR   ChiTaRS; B2M; human.
DR   EvolutionaryTrace; K7N5M4; -.
DR   GO; GO:0042101; C:T cell receptor complex; IEA:UniProtKB-ARBA.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002376; P:immune system process; IEA:UniProtKB-KW.
DR   CDD; cd05769; IgC1_TCR_beta; 1.
DR   CDD; cd05899; IgV_TCR_beta; 1.
DR   FunFam; 2.60.40.10:FF:001090; T cell receptor beta constant 1; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR050413; TCR_beta_variable.
DR   PANTHER; PTHR23268:SF30; T CELL RECEPTOR BETA CHAIN MC.7.G5-RELATED; 1.
DR   PANTHER; PTHR23268; T-CELL RECEPTOR BETA CHAIN; 1.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   1: Evidence at protein level;
KW   3D-structure {ECO:0007829|PDB:3PQY, ECO:0007829|PDB:4EN3};
KW   Cell membrane {ECO:0000256|ARBA:ARBA00022475};
KW   Disulfide bond {ECO:0000256|ARBA:ARBA00023157};
KW   Glycoprotein {ECO:0000256|ARBA:ARBA00023180};
KW   Immunity {ECO:0000256|ARBA:ARBA00022859};
KW   Membrane {ECO:0000256|ARBA:ARBA00023136};
KW   Metal-binding {ECO:0007829|PDB:6BJ2};
KW   Signal {ECO:0000256|ARBA:ARBA00022729}; Zinc {ECO:0007829|PDB:6BJ2}.
FT   DOMAIN          3..111
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          128..237
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   BINDING         142
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0007829|PDB:6BJ2"
FT   BINDING         159
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0007829|PDB:6BJ2"
FT   BINDING         161
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0007829|PDB:6BJ2"
FT   DISULFID        26..94
FT                   /evidence="ECO:0007829|PDB:4EN3, ECO:0007829|PDB:4MNH"
FT   DISULFID        150..215
FT                   /evidence="ECO:0007829|PDB:3PQY, ECO:0007829|PDB:4EN3"
SQ   SEQUENCE   259 AA;  29288 MW;  8B762DD690E0B1B5 CRC64;
     ADPEADIYQT PRYLVIGTGK KITLECSQTM GHDKMYWYQQ DPGMELHLIH YSYGVNSTEK
     GDLSSESTVS RIRTEHFPLT LESARPSHTS QYLCASSENS GTGRIYEQYF GPGTRLTVTE
     DLKNVFPPEV AVFEPSEAEI SHTQKATLVC LATGFYPDHV ELSWWVNGKE VHSGVCTDPQ
     PLKEQPALND SRYALSSRLR VSATFWQNPR NHFRCQVQFY GLSENDEWTQ DRAKPVTQIV
     SAEAWGRADS RGGLEVLFQ
//
